AngioDynamics (NASDAQ:ANGO) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS

AngioDynamics (NASDAQ:ANGO) posted its quarterly earnings data on Wednesday. The medical instruments supplier reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.07, RTT News reports. AngioDynamics had a negative return on equity of 5.86% and a negative net margin of 83.95%. AngioDynamics updated its FY 2025 guidance to -0.380–0.340 EPS.

AngioDynamics Trading Up 1.4 %

Shares of NASDAQ:ANGO opened at $9.40 on Wednesday. The firm has a market capitalization of $381.96 million, a PE ratio of -1.54 and a beta of 0.59. AngioDynamics has a 1-year low of $5.26 and a 1-year high of $9.63. The business’s 50 day moving average is $7.82 and its 200-day moving average is $7.27.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ANGO. HC Wainwright reiterated a “buy” rating and set a $14.00 price target on shares of AngioDynamics in a report on Tuesday, December 10th. Canaccord Genuity Group cut their target price on shares of AngioDynamics from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Friday, October 4th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.